Virnext

Virnext is a specialized biotechnology company and technological transfer platform based in Lyon, France, originating from the VirPath laboratory at Université Claude Bernard Lyon 1. The company provides comprehensive CRO services focused on the evaluation of antiviral strategies and the development of vaccine candidates against respiratory viruses, including influenza and SARS-CoV-2. Utilizing its proprietary EZ-Vir platform, Virnext offers high-throughput screening, preclinical validation, and clinical trial support for pharmaceutical and biotech partners. Their expertise spans drug repurposing, decontamination technologies, and the characterization of viral pathogens in BSL-2 and BSL-3 environments. The organization bridges the gap between academic research and industrial application, facilitating the rapid development of innovative anti-infective solutions.